Masaaki Ishibashi

Mechanism of the lipid-lowering effect of ethyl all-cis-5,8,11,14,17-icosapentaenoate

Kiyoshi Mizuguchi, Takashi Yano, Yasuo Tanaka et al. · European Journal of Pharmacology · 1993 · 30 citations

Biochemistry, Organic Chemistry, Lipid Science +3

Possible involvement of TRPM2 activation in 5-fluorouracil-induced myelosuppression in mice

Masaaki Ishibashi, Masakazu Ishii, Shinichiro Yamamoto et al. · European Journal of Pharmacology · 2020 · 21 citations

Inflammation, Molecular Pharmacology, Cytokine +11

Hypolipidemic Effect of Ethyl all-cis-5,8,11,14,17-Icosapentaenoate (EPA-E) in Rats.

Kiyoshi Mizuguchi, Takashi Yano, Masahiro Kojima et al. · The Japanese Journal of Pharmacology · 1992 · 18 citations · Full text

Metabolic Syndrome, Triton Wr-1339, Biochemistry +14

Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein

Kiyoshi Mizuguchi, Takashi Yano, Masaaki Ishibashi et al. · European Journal of Pharmacology · 1993 · 17 citations

Lipid Analysis, Ethyl All-cis-5,8,11,14,17-icosapentaenoate Modifies, Lipid Synthesis +7

Protective Action of Ulinastatin against Cisplatin Nephrotoxicity in Mice and Its Effect on the Lysosomal Fragility

Fumiaki Yamasaki, Masaaki Ishibashi, Masanori Nakakuki et al. · Nephron · 1996 · 17 citations

Protective Action, Lipid Peroxidation, Cell Death +18